Europe PMCopen access
NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants
Immunogenicity, Nvx-cov2373, Covid-19 Vaccine Booster, Omicron Subvariants, Bivalent Mrna Vaccine
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 253545
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.